Aspen Bad Oldesloe GmbH
DEX1721R.HRB9561HL
Firmensitz
Industriestr. 32-36
23843 Bad Oldesloe
Schleswig-Holstein
Deutschland
Kontakt
Geschäftsführung
Chris Mynhard Botha
Managing Director
Seit 5. September 2024
Lorraine Angela Hill
Managing Director
Seit 26. Oktober 2009
Elisabeth Jeanne Alice Brigitte Marie PerrinEhemalig
Managing Director
16. November 2022 – 5. September 2024
Jean-Charles Georges RoussetEhemalig
Managing Director
12. Juni 2019 – 16. November 2022
Morne GeyserEhemalig
Managing Director
4. August 2010 – 3. September 2018
Roland SuckEhemalig
Managing Director
16. November 2022 – 21. Juli 2023
Finanzen
| Jahr | Umsatz | Gewinn | Bilanzsumme | Eigenkapitalquote |
|---|---|---|---|---|
| 2024 | 81.149.703 € | -3.744.706 € | 129.528.916 € | 64.5% |
| 2023 | 72.166.779 € | -865.480 € | 128.922.509 € | 67.7% |
| 2022 | 66.585.062 € | -11.748.124 € | 118.599.758 € | 65.9% |
| 2021 | 68.783.091 € | -4.983.118 € | 113.075.099 € | 66.2% |
| 2020 | 65.409.631 € | 540.591 € | 106.543.716 € | 75.0% |
Branche
NACE 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen ErzeugnissenWZ 21.20.0Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen ErzeugnissenISIC 2100Manufacture of pharmaceuticals, medicinal chemical and botanical productsNAICS 325199Basic Chemical ManufacturingNAICS 325411Pharmaceutical and Medicine ManufacturingNAICS 325412Pharmaceutical and Medicine ManufacturingNAICS 325413Pharmaceutical and Medicine ManufacturingNAICS 325414Pharmaceutical and Medicine ManufacturingNAICS 339113Medical Equipment and Supplies ManufacturingUKSIC 21.20Manufacture of pharmaceutical preparationsNACE2025 21.20Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen
Rohdaten
{
"id": "d6e4aae0-cda3-4e90-9b1e-596024d0a905",
"euId": "DEX1721R.HRB9561HL",
"name": "Aspen Bad Oldesloe GmbH",
"legalForm": "GmbH",
"status": "active",
"foundationDate": "2009-10-26T00:00:00",
"vatId": "DE266185487",
"hq": {
"line2": null,
"street": "Industriestr. 32-36",
"city": "Bad Oldesloe",
"zipCode": "23843",
"state": "SH",
"country": "DE",
"latitude": 53.800589,
"longitude": 10.3982645882126
},
"contactData": {
"emails": [
"contact@eu.aspenpharma.com"
],
"phones": [
"+49 453189400"
],
"websites": [
"https://aspenpharma.com/"
],
"faxes": [
"+49 4531894090"
]
},
"managers": [
{
"name": "Chris Mynhard Botha",
"position": "Managing Director",
"startDate": "2024-09-05T00:00:00",
"endDate": null
},
{
"name": "Elisabeth Jeanne Alice Brigitte Marie Perrin",
"position": "Managing Director",
"startDate": "2022-11-16T00:00:00",
"endDate": "2024-09-05T00:00:00"
},
{
"name": "Jean-Charles Georges Rousset",
"position": "Managing Director",
"startDate": "2019-06-12T00:00:00",
"endDate": "2022-11-16T00:00:00"
},
{
"name": "Lorraine Angela Hill",
"position": "Managing Director",
"startDate": "2009-10-26T00:00:00",
"endDate": null
},
{
"name": "Morne Geyser",
"position": "Managing Director",
"startDate": "2010-08-04T00:00:00",
"endDate": "2018-09-03T00:00:00"
},
{
"name": "Roland Suck",
"position": "Managing Director",
"startDate": "2022-11-16T00:00:00",
"endDate": "2023-07-21T00:00:00"
}
],
"industry": {
"isic": [
"2100"
],
"nace": [
"21.20"
],
"nace2025": [
"21.20"
],
"naics": [
"325199",
"325411",
"325412",
"325413",
"325414",
"339113"
],
"uksic": [
"21.20"
],
"wz": [
"21.20.0"
]
},
"financials": [
{
"year": 2019,
"currency": "EUR",
"capital": 50000,
"capitalIsEstimate": false,
"balanceTotal": 97505800.37,
"balanceTotalIsEstimate": false,
"earnings": 117182.89,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 59399427.15,
"revenueIsEstimate": false,
"revenueCagr": 0,
"revenueCagrIsEstimate": false,
"returnOnSales": 0.19727949514408744,
"returnOnSalesIsEstimate": false,
"equity": 79316176.76,
"equityIsEstimate": false,
"equityRatio": 81.3450855836506,
"equityRatioIsEstimate": false,
"cash": 153979.84,
"cashIsEstimate": false,
"receivables": 26985797.89,
"receivablesIsEstimate": false,
"liabilities": 1735475.45,
"liabilitiesIsEstimate": false
},
{
"year": 2020,
"currency": "EUR",
"capital": 50000,
"capitalIsEstimate": false,
"balanceTotal": 106543715.7,
"balanceTotalIsEstimate": false,
"earnings": 540591.37,
"earningsIsEstimate": false,
"earningsCagr": 361.3227835565414,
"earningsCagrIsEstimate": false,
"revenue": 65409630.79,
"revenueIsEstimate": false,
"revenueCagr": 10.11828552626033,
"revenueCagrIsEstimate": false,
"returnOnSales": 0.8264706029844264,
"returnOnSalesIsEstimate": false,
"equity": 79856768.13,
"equityIsEstimate": false,
"equityRatio": 74.95211482473198,
"equityRatioIsEstimate": false,
"cash": 116848.5,
"cashIsEstimate": false,
"receivables": 26105450.96,
"receivablesIsEstimate": false,
"liabilities": 3838596.23,
"liabilitiesIsEstimate": false
},
{
"year": 2021,
"currency": "EUR",
"capital": 50000,
"capitalIsEstimate": false,
"balanceTotal": 113075098.61,
"balanceTotalIsEstimate": false,
"earnings": -4983118.23,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 68783091.28,
"revenueIsEstimate": false,
"revenueCagr": 7.609277811462567,
"revenueCagrIsEstimate": false,
"returnOnSales": -7.24468490332149,
"returnOnSalesIsEstimate": false,
"equity": 74873649.9,
"equityIsEstimate": false,
"equityRatio": 66.21586080436849,
"equityRatioIsEstimate": false,
"cash": 201968.54,
"cashIsEstimate": false,
"receivables": 15656932.05,
"receivablesIsEstimate": false,
"liabilities": 5667579.34,
"liabilitiesIsEstimate": false
},
{
"year": 2022,
"currency": "EUR",
"capital": 50000,
"capitalIsEstimate": false,
"balanceTotal": 118599757.77,
"balanceTotalIsEstimate": false,
"earnings": -11748123.93,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 66585061.97,
"revenueIsEstimate": false,
"revenueCagr": 3.879898642314683,
"revenueCagrIsEstimate": false,
"returnOnSales": -17.64378312855387,
"returnOnSalesIsEstimate": false,
"equity": 78125525.97,
"equityIsEstimate": false,
"equityRatio": 65.8732593042125,
"equityRatioIsEstimate": false,
"cash": 169976.91,
"cashIsEstimate": false,
"receivables": 16097980.88,
"receivablesIsEstimate": false,
"liabilities": 1858856.14,
"liabilitiesIsEstimate": false
},
{
"year": 2023,
"currency": "EUR",
"capital": 50000,
"capitalIsEstimate": false,
"balanceTotal": 128922509.3,
"balanceTotalIsEstimate": false,
"earnings": -865480.46,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 72166778.7,
"revenueIsEstimate": false,
"revenueCagr": 4.987783229382692,
"revenueCagrIsEstimate": false,
"returnOnSales": -1.199278221351454,
"returnOnSalesIsEstimate": false,
"equity": 87260045.51,
"equityIsEstimate": false,
"equityRatio": 67.6841041830389,
"equityRatioIsEstimate": false,
"cash": 24739.09,
"cashIsEstimate": false,
"receivables": 19740473.91,
"receivablesIsEstimate": false,
"liabilities": 5097463.25,
"liabilitiesIsEstimate": false
},
{
"year": 2024,
"currency": "EUR",
"capital": 50000,
"capitalIsEstimate": false,
"balanceTotal": 129528916.01,
"balanceTotalIsEstimate": false,
"earnings": -3744706.28,
"earningsIsEstimate": false,
"earningsCagr": 0,
"earningsCagrIsEstimate": false,
"revenue": 81149702.92,
"revenueIsEstimate": false,
"revenueCagr": 5.538595211628605,
"revenueCagrIsEstimate": false,
"returnOnSales": -4.6145656056087505,
"returnOnSalesIsEstimate": false,
"equity": 83515339.23,
"equityIsEstimate": false,
"equityRatio": 64.4762125729149,
"equityRatioIsEstimate": false,
"cash": 17268.95,
"cashIsEstimate": false,
"receivables": 19422968.61,
"receivablesIsEstimate": false,
"liabilities": 2758961.84,
"liabilitiesIsEstimate": false
}
]
}